AT

Atomera Inc.

Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.

ATOM | NDAQ

Overview

Corporate Details

ISIN(s):
US04965B1008
LEI:
Country:
United States of America
Address:
N/A
Website:
atomera.com
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Atomera Inc. is a semiconductor materials and intellectual property (IP) licensing company that develops, commercializes, and licenses proprietary technologies for the semiconductor industry. The company's core offering is its patented Mears Silicon Technology (MST®), a quantum-engineered material designed to enhance transistors. MST improves semiconductor performance by enabling faster and more controlled electron movement and better diffusion control of dopants. This technology allows manufacturers to create chips with higher performance, lower power consumption, and increased density. Atomera targets markets including mobile/5G, Internet of Things (IoT), and infrastructure, with applications spanning logic and processors, memory (DRAM, SRAM), FinFETs, analog and power devices, and image sensors. The company supports its licensees with engineering services and simulation tools like MSTcad™.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Atomera Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Atomera Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.